ResearcherColumbia UniversityNo recent work listed
Joseph DiNorcia
Matched on ORCID iD 0000-0002-0212-7182; OpenAlex author ID A5088129867. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2012: 1 paper · 2013: none · 2014: 1 paper
Papers 2
- Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer. First author DOI 10.1007/s00268-013-2384-z↗
- RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. Co-author DOI 10.1007/s11605-011-1754-9↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Megan D. Winner · 2 shared papers, 2012–2014 · strength 0.07
- Paper Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients wit… DOI 10.1007/s00268-013-2384-z↗
- Paper RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model… DOI 10.1007/s11605-011-1754-9↗
- John Allendorf · 2 shared papers, 2012–2014 · strength 0.07
- Paper Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients wit… DOI 10.1007/s00268-013-2384-z↗
- Paper RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model… DOI 10.1007/s11605-011-1754-9↗
- Irene Epelboym · 1 shared paper, 2014 · strength 0.04
- Beth Schrope · 1 shared paper, 2014 · strength 0.04
- John A. Chabot · 1 shared paper, 2014 · strength 0.04
- Wanglong Qiu · 1 shared paper, 2012 · strength 0.03
- Gloria Huei-Ting Su · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.